Dr Joel Collins is a consultant Clinical Haematologist (Physician). A Clinical Haematologist is a specialist in blood disorders such as blood cancer, abnormal blood counts, bleeding disorders, clotting disorders and other issues including iron and other vitamin deficiencies.
He holds a Bachelor of Medicine and Surgery from Griffith University in Queensland. He is a fellow of the Royal Australasian College of Physicians, having completed his advanced training between the two major Queensland tertiary hospitals - the Royal Brisbane and Women’s Hospital and the Princess Alexandra Hospital. Whilst completing his training, Dr Collins held the position of Chief Medical Registrar at the Royal Brisbane and Women’s Hospital.
Dr Collins currently holds an appointment as a Staff Specialist at the Toowoomba Base Hospital, and is credentialled at St Andrew's Hospital (Toowoomba), and St Vincent's Hospital (Toowoomba) and the Toowoomba Hospice.
Recognising that patients from the Darling Downs and Western Queensland prefer to be treated locally, Dr Collins aims to keep all patient care locally where this is possible.
Dr Collins has been working closely with the oncology staff and executive at St Andrew's Hospital, and can now offer treatment for many high grade haematological cancers locally at St Andrew's Hospital. Previously these patients were treated in Brisbane, or at the Base Hospital.
Dr Collins has published research in both local and international medical journals, and has been a speaker at a number of national conferences. He has ongoing active research interest in malignant haematology in particular, multiple myeloma. He is a Senior Lecturer at the University of Queensland, and the Rural Clinical School. His other professional memberships include Haematology Society of Australia and New Zealand (HSANZ), Australasian Lymphoma and Leukaemia Group (ALLG), American Society of Hematology (ASH) and the European Haematology Association (EHA).
Dr Collins was a recipient and current holder of one of five research fellowships for research into the immunobiology of myeloma